Evidence map›Paper›PMID 40188702›Full record

ArticleThe International journal on drug policy2025

Recruiting opioid treatment program administrators for a national survey: Outcomes and lessons learned.

Benjamin R Brady, Beth E Meyerson, Alissa Davis, Greg A Carter, Sara Najar, Alexa Martinez, Caleb Mueller, Elias O Higbie, Holden Dal Ponte, Khino Moneva and 6 more

Abstract read
In one paragraph

Article in The International journal on drug policy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Benjamin R BradyWestern Michigan University, College of Health and Human Services, 1903W. Michigan Ave., Kalamazoo, MI 49001, USA; University of Arizona College of Medicine-Tucson, Harm Reduction Research Lab, 1501N Campbell Ave, Tucson, AZ 85724, USA; University of Arizona, Comprehensive Center for Pain and Addiction, 1501N Campbell Ave, Tucson, AZ 85724, USA. Electronic address: benjamin.brady@wmich.edu.
Beth E MeyersonUniversity of Arizona College of Medicine-Tucson, Harm Reduction Research Lab, 1501N Campbell Ave, Tucson, AZ 85724, USA; University of Arizona, Comprehensive Center for Pain and Addiction, 1501N Campbell Ave, Tucson, AZ 85724, USA.
Alissa DavisUniversity of Arizona College of Medicine-Tucson, Harm Reduction Research Lab, 1501N Campbell Ave, Tucson, AZ 85724, USA; Columbia University, School of Social Work, 1255 Amsterdam Ave, NY, NY 10027, USA.
Greg A CarterUniversity of Arizona College of Medicine-Tucson, Harm Reduction Research Lab, 1501N Campbell Ave, Tucson, AZ 85724, USA; Indiana University, School of Nursing, 600 Barnhill Dr, Indianapolis, IN 46202, USA.
Sara NajarWestern Michigan University, College of Education and Human Development, 1903W Michigan Ave, Kalamazoo, MI 49008, USA.
Alexa MartinezUniversity of Arizona College of Medicine-Tucson, Harm Reduction Research Lab, 1501N Campbell Ave, Tucson, AZ 85724, USA.
Caleb MuellerUniversity of Arizona College of Medicine-Tucson, Harm Reduction Research Lab, 1501N Campbell Ave, Tucson, AZ 85724, USA.
Elias O HigbieUniversity of Arizona College of Medicine-Tucson, Harm Reduction Research Lab, 1501N Campbell Ave, Tucson, AZ 85724, USA.
Holden Dal PonteUniversity of Arizona College of Medicine-Tucson, Harm Reduction Research Lab, 1501N Campbell Ave, Tucson, AZ 85724, USA.
Khino MonevaUniversity of Arizona College of Medicine-Tucson, Harm Reduction Research Lab, 1501N Campbell Ave, Tucson, AZ 85724, USA.
Natalia C BentzUniversity of Arizona College of Medicine-Tucson, Harm Reduction Research Lab, 1501N Campbell Ave, Tucson, AZ 85724, USA.
Linnea B Linde-KriegerUniversity of Arizona College of Medicine-Tucson, Harm Reduction Research Lab, 1501N Campbell Ave, Tucson, AZ 85724, USA; University of Arizona, Comprehensive Center for Pain and Addiction, 1501N Campbell Ave, Tucson, AZ 85724, USA.
Zhanette CoffeeUniversity of Arizona College of Medicine-Tucson, Harm Reduction Research Lab, 1501N Campbell Ave, Tucson, AZ 85724, USA; University of Arizona, Comprehensive Center for Pain and Addiction, 1501N Campbell Ave, Tucson, AZ 85724, USA; University of Arizona, College of Nursing, 1305N Martin Ave, Tucson, AZ 85721, USA.
Arlene N MahoneyUniversity of Arizona College of Medicine-Tucson, Harm Reduction Research Lab, 1501N Campbell Ave, Tucson, AZ 85724, USA; Southwest Recovery Alliance, Phoenix, AZ, USA.
David FrankUniversity of Arizona College of Medicine-Tucson, Harm Reduction Research Lab, 1501N Campbell Ave, Tucson, AZ 85724, USA; New York University, School of Global Public Health, 708 Broadway, New York, NY 10003, USA.
Richard A CrosbyUniversity of Arizona College of Medicine-Tucson, Harm Reduction Research Lab, 1501N Campbell Ave, Tucson, AZ 85724, USA; University of Kentucky, College of Public Health, 111 Washington Ave, Lexington, KY 40536, USA.

Funding

Methadone Patient Access to Collaborative Treatment (MPACT)R33DA059889 · NIDA · UNIVERSITY OF ARIZONA · PI Beth Meyerson · 2025 to 2026
$2.3M
Methadone Patient Access to Collaborative Treatment (MPACT)R61DA059889 · NIDA · UNIVERSITY OF ARIZONA · PI MEYERSON, BETH · 2023 to 2024
$951k
NIDA NIH HHS R33 DA059889NIDA NIH HHS R61 DA059889
6 · The paper itself

Abstract

backgroundGlobally, access to opioid use disorder treatment remains insufficient. In the US, recent policy changes for opioid use disorder treatment present opportunities to improve patient access to evidence-based methadone treatment. To evaluate the adoption and sustained implementation of these changes, access to a national, representative sample of opioid treatment programs (OTPs, 'methadone clinics') is essential. This study reports the outcomes of a recruitment effort for a national sample of OTP administrators.

methodsA stratified random sample of 1000 OTPs was drawn from the US Substance Abuse and Mental Health Services Administration's National Opioid Treatment Program Directory. Stratification was based on state-level OTP regulations and county-level opioid overdose rates. OTPs identified as tribal serving, located in jails or prisons, or requiring corporate approval for research participation were deemed ineligible and excluded from the sample. A team of trained researchers called OTP clinics seeking to speak with administrators and obtain their email addresses for study recruitment.

resultsIn the sample, 885 OTPs were eligible for study recruitment. We contacted a live person by phone at 73 % of OTPs and an administrator at 23 %. Of the administrators reached, 77 % agreed to receive study information and 22 % completed the survey. Total caller time was 276.5 hours at a cost of $5530.

conclusionDespite a rigorous sampling frame, and a costly and considerable effort, US OTP recruitment outcomes were suboptimal. Innovative strategies are needed to improve administrator recruitment. Recommendations include updating the SAMHSA directory to include administrator contact information (name, phone, email), using diverse outreach methods, and refining call scripts to improve engagement.

Indexed as

Administrative PersonnelOpiate Substitution TreatmentOpioid-Related DisordersSubstance Abuse Treatment CentersHealth Services AccessibilityHumansMethadoneUnited StatesMethadoneMethadoneOpioid treatment programsResearch recruitment

Identifiers

PMID40188702
PMCPMC12096395

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.